According to GlobalData’s Clinical Trial Database, six out of the 11 planned trials disclosed in the last two weeks will be investigating Covid-19 boosters and therapeutics....
How technology can enable clinical trials participation, leading to lower participant burden and better data....
The pandemic forced clinical trial sponsors to change their processes, with a more technology-driven approach and, according to a new study by Medidata, the sector is now “stronger than ever” as a result....
COVID-19 safety precautions have been rescinded as many try to to return to a sense of pre-pandemic normalcy. But the reality of disabled and immunocompromised people remains forgotten, causing them to feel left behind and further pushed out of society, disability advocates say....
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National Press Foundation Q&A....
It's been more than a week since COVID-19 vaccinations were approved for kids ages 6 months to 5 years old, but some hospitals are still waiting to schedule appointments....
Researchers estimate that COVID-19 vaccine shots prevented 1.9 million deaths in the United States during the first year they became available....
The challenges of the pandemic may have given the clinical research profession the gift of perspective that will positively affect the outlook on our industry’s collective future....
The Centers for Disease Control and Prevention authorized the COVID-19 vaccine for kids under five and UW Health experts say they’re ready to start rolling out vaccinations in Wisconsin....
A research team led by University of Wisconsin–Madison virologist Yoshihiro Kawaoka and colleagues in Japan show that the BA.2 subvariant of omicron is similar to BA.1 in both the severity of illness it causes and in its ability to cause infection....
English
Español
